Radium 223 for the treatment of metastatic castration | 合法藥品大搜索
由JMiranda著作·2019—Thetreatmentofpatientswithmetastaticcastration-resistantprostatecancer(mCRPC)hasevolveddramaticallyintherecentyearswiththeapprovalof ...
由 J Miranda 著作 · 2019 — The treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) has evolved dramatically in the recent years with the approval of ...
Radium 223 prostate cancer Radium-223 side effects Ra 223 ALSYMPCA Radium 223 treatment Prostate cancer nih mCRPC treatment ERA 223 Alsymca ALSYMPCA Alpha emitter radium-223 and survival in metastatic prostate cancer hoskin p et al. lancet oncol 2014;15: 1397406 Era 223 Radium 223 Radium-223 prostate cancer CARD trial ra 223健保 鐳223自費 鐳223治療處置費 ra 223半衰期 鐳223效果 鐳223半衰期 鐳223衛教 Radium 223 prostate cancer Radium-223 side effects Ra 223 Radium 223 treatment Prostate cancer nih mCRPC treatment ERA 223 抗組織胺吃多了會怎麼樣 vena抗組織胺 vena副作用 vena作用時間 葡萄糖食鹽水注射液 副作用 易痛寧頭痛 普拿疼鼻炎錠 普拿疼加強錠有消炎作用嗎
Addition of radium | 合法藥品大搜索
由 M Smith 著作 · 2019 · 被引用 174 次 — Radium-223 improves overall survival and delays the onset of symptomatic skeletal events in patients with castration-resistant prostate cancer ... Read More
Clinical response to radium | 合法藥品大搜索
由 I Zhang 著作 · 2018 · 被引用 1 次 — ... undergo treatment with radium-223 will experience an improvement in pain and, ... dichloride in men with metastatic castrate-resistant prostate cancer. Read More
Combination radium | 合法藥品大搜索
由 MC Cursano 著作 · 2020 · 被引用 7 次 — Combinations of radium-223 with these agents or novel drugs have been ... patients with bone metastases from castration-resistant prostate cancer: A review. Read More
Efficacy and safety of radium | 合法藥品大搜索
由 P Hoskin 著作 · 2014 · 被引用 339 次 — Interpretation: Radium-223 is effective and well tolerated in patients with castration-resistant prostate cancer and symptomatic bone metastases, irrespective ... Read More
Radium 223 for the treatment of metastatic castration | 合法藥品大搜索
由 J Miranda 著作 · 2019 — The treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) has evolved dramatically in the recent years with the approval of ... Read More
Radium | 合法藥品大搜索
由 F Saad 著作 · 2016 · 被引用 234 次 — Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open- ... Read More
Radium | 合法藥品大搜索
由 S McGann 著作 · 2015 · 被引用 20 次 — (223)Ra is a first-in-class α-particle-emitting radioactive agent that is ... various combinations of the terms radium, hormone-refractory prostate cancer, ... Read More
Radium | 合法藥品大搜索
2013年8月2日 — Results from a phase III trial called ALSYMPCA show that radium-223 dichloride (Xofigo®) improves overall survival in men with advanced ... Read More
Radium | 合法藥品大搜索
由 MI Suominen 著作 · 2017 · 被引用 108 次 — Purpose: Radium-223 dichloride (radium-223, Xofigo), a targeted alpha therapy, is currently used for the treatment of patients with ... Read More
Radium | 合法藥品大搜索
由 MJ Morris 著作 · 2019 · 被引用 20 次 — The targeted alpha therapy radium-223 ( 223 Ra) can prolong survival in men with castration-resistant prostate cancer (CRPC) who have ... Read More
相關資訊整理
【鐳治骨注射液】本品用於治療去勢抗性攝護腺癌(castration-resistant prostate cancer)病患,其合併有症狀的骨轉移且尚未有臟器轉移者。
藥品名稱:鐳治骨注射液許可證字號:衛部藥輸字第R00091號許可證種類:製 劑適應症:本品用於治療去勢抗性攝護腺癌(castration-...
【舒攝癌注射液】前列腺癌
藥品名稱:舒攝癌注射液許可證字號:衛署藥輸字第017096號許可證種類:製 劑適應症:前列腺癌劑型:藥品類別:限由醫師使用主成分...
【"居禮" 鈣錠】妊娠婦及授乳婦防止鈣缺乏預防牙齒疾患、脫毛。助成全骨骼牙齒發育、預防蛀牙、佝僂病、改善腺病質、滲出性體質。食物性鈣缺乏、自主神經之鎮靜過敏性疾病、軟骨症
藥品名稱:"居禮"鈣錠許可證字號:衛署藥製字第020204號許可證種類:製 劑適應症:妊娠婦及授乳婦防止鈣缺乏預防牙齒疾患、脫毛...
【維泰凱20毫克/毫升口服溶液】適用於有NTRK 基因融合的實體腫瘤之成人和兒童病人,並應符合以下三項條件:1、具NTRK基因融合且無已知的後天阻抗性突變(acquired resistance mutation);2、為轉移性實體腫瘤,或手術切除極可能造成嚴重病症(severe morbidity);3、沒有合適的替代治療選項,或於治療後發生疾病惡化。
藥品名稱:維泰凱20毫克/毫升口服溶液許可證字號:衛部藥輸字第027746號許可證種類:製 劑適應症:適用於有NTRK基因融合的實體...
【維泰凱 膠囊100毫克】適用於有NTRK 基因融合的實體腫瘤之成人和兒童病人,並應符合以下三項條件:1、具NTRK基因融合且無已知的後天阻抗性突變(acquired resistance mutation);2、為轉移性實體腫瘤,或手術切除極可能造成嚴重病症(severe morbidity);3、沒有合適的替代治療選項,或於治療後發生疾病惡化。
藥品名稱:維泰凱膠囊100毫克許可證字號:衛部藥輸字第027748號許可證種類:製 劑適應症:適用於有NTRK基因融合的實體腫瘤之成...
【維泰凱 膠囊25毫克】適用於有NTRK 基因融合的實體腫瘤之成人和兒童病人,並應符合以下三項條件:1、具NTRK基因融合且無已知的後天阻抗性突變(acquired resistance mutation);2、為轉移性實體腫瘤,或手術切除極可能造成嚴重病症(severe morbidity);3、沒有合適的替代治療選項,或於治療後發生疾病惡化。
藥品名稱:維泰凱膠囊25毫克許可證字號:衛部藥輸字第027747號許可證種類:製 劑適應症:適用於有NTRK基因融合的實體腫瘤之成人...
【腎臟透析液三六0號(甲)】配合人工腎臟用以清洗病人血中尿毒
藥品名稱:腎臟透析液三六0號(甲)許可證字號:衛署藥製字第029207號許可證種類:製 劑適應症:配合人工腎臟用以清洗病人血中...